Home -> Law Blog Directory -> Personal Injury Law Blogs -> Chicago Medical Malpractice Lawyer Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Chicago Medical Malpractice Lawyer BlogNRC sanctions Pa. doc in flawed cancer treatments
By Hurley, McKenna & Mertz
The Nuclear Regulatory Commission ?has sanctioned a doctor who performed nearly 100 botched prostate cancer procedures at Philadelphia's VA Medical Center.? (Philadelphia AP, 2/24). Previous blogs discuss the concerning pattern of medical care provided by Dr. Gary Kao, and as a personal injury and medical malpractice attorney in Chicago, I am pleased that some form of justice has been served on the doctor.
The NRC says ?Dr. Gary Kao cannot take part in agency-related activities without undergoing more training,? after finding that Dr. Kao was responsible for 91 botches procedures in which veterans received incorrect dosages of radioactive seeds implanted to kill cancer cells in the prostate. Many patients received doses that were insufficient, but had seeds implanted carelessly in nearby organs and surrounding tissues.
Last year, the NRC fined the VA hospital $227,500 and now are imposing sanctions on Dr. Kao. Although this is certainly a step, Dr. Kao?s carelessness should not be forgotten and he should be monitored further to ensure patient safety.
Full post as published by Chicago Medical Malpractice Lawyer Blog on March 04, 2011 (boomark / email).
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Uninsured Patients
Scripps Health agrees to refund 35% of overpriced medical treatments in class action settlement.
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
$5.4 Million Quebec Breast Cancer Wait List Class Action Settlement Approved
$5.4 Million Quebec Breast Cancer Class Action Settlement Approved
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Fosamax
Possible Link with Esophageal Cancer

Studies Fault Popular Prostate Cancer Test
STARTUP WILL OFFER PATIENTS a genetic profile of their cancer. Many cancer researchers believe tha
MICKEY KAUS: So if one of these promising new cancer treatments winds up working 25% of the time,
Fake Cancer 'Cure' Product Warnings
Cancer Treatment Costs Skyrocketing, Study Finds
Palladin Gene Mutation of Chromosome 4 in Pancreatic Cancer









